Research Analysts Offer Predictions for INSP FY2027 Earnings

Inspire Medical Systems, Inc. (NYSE:INSP) – Research analysts at Leerink Partnrs cut their FY2027 earnings estimates for shares of Inspire Medical Systems in a note issued to investors on Monday, November 25th. Leerink Partnrs analyst M. Kratky now anticipates that the company will earn $3.57 per share for the year, down from their prior estimate of $3.63. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ FY2028 earnings at $5.69 EPS.

Other equities research analysts also recently issued reports about the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Truist Financial reissued a “buy” rating and set a $240.00 target price (up from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Stifel Nicolaus restated a “hold” rating and issued a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Piper Sandler reiterated an “overweight” rating and set a $260.00 price objective (up previously from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Finally, Wells Fargo & Company lifted their target price on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Inspire Medical Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $233.58.

Inspire Medical Systems Stock Up 5.7 %

Shares of INSP stock opened at $199.55 on Tuesday. The stock has a 50-day simple moving average of $199.36 and a 200 day simple moving average of $175.58. The stock has a market capitalization of $5.98 billion, a P/E ratio of 186.49 and a beta of 1.36. Inspire Medical Systems has a fifty-two week low of $123.00 and a fifty-two week high of $257.40.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. During the same period last year, the company posted ($0.29) EPS. The firm’s quarterly revenue was up 32.6% on a year-over-year basis.

Hedge Funds Weigh In On Inspire Medical Systems

Institutional investors and hedge funds have recently modified their holdings of the stock. SouthState Corp purchased a new position in Inspire Medical Systems in the second quarter valued at about $27,000. True Wealth Design LLC acquired a new position in Inspire Medical Systems in the third quarter worth approximately $30,000. Farther Finance Advisors LLC raised its position in Inspire Medical Systems by 1,158.3% during the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock valued at $32,000 after acquiring an additional 139 shares in the last quarter. GAMMA Investing LLC lifted its stake in Inspire Medical Systems by 559.3% in the third quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock valued at $38,000 after acquiring an additional 151 shares during the last quarter. Finally, Quarry LP grew its position in Inspire Medical Systems by 105.4% in the second quarter. Quarry LP now owns 343 shares of the company’s stock worth $46,000 after acquiring an additional 176 shares in the last quarter. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $220.00, for a total value of $176,000.00. Following the completion of the sale, the director now owns 23,140 shares in the company, valued at $5,090,800. This represents a 3.34 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.